Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?
- PMID: 15614707
- DOI: 10.1086/426596
Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?
Comment on
-
Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.Clin Infect Dis. 2005 Jan 1;40(1):158-63. doi: 10.1086/426595. Epub 2004 Dec 6. Clin Infect Dis. 2005. PMID: 15614706
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
